The economic burden of melanoma in the UK: A stage-specific cost analysis underscoring the importance of prevention and early diagnosis

This article reports the average cumulative costs of melanoma by stage in 2023 and models costs over the next ten years. This data highlights the marked difference in cost between stage I and IV melanoma, with stage IV melanoma costing 22.5 times more than stage I melanoma in 2023. This cost difference is predicted to further increase over the next decade which emphasises the need to deliver a comprehensive melanoma public health strategy that includes primary prevention and early detection.